Mumbai: Bai Jerbai Wadia Hospital for Children has launched a unique initiative to provide life-saving cystic fibrosis (CF) medication—costing Rs 1.5 crore per child annually—free of charge to 40 ...

Electromed, Inc. (NYSE:ELMD) is one of the 11 Best Long Term Low Risk Stocks to Invest in. Analysts maintain a Buy rating ...

Patients with bronchiectasis from different European countries have strikingly different variations in microbiome composition and resistome.

One double lung transplant recipient offers advice to former UFC fighter Ben Askren after his surgery, while a doctor ...

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

When you use a nebulizer, the directions are simple – breathe normally. It’s true that there are steps before and after ...

The NHS will offer a once-daily triple therapy for cystic fibrosis to hundreds more patients, including those with rare ...

Bristol-Myers Squibb recently wrapped up a pivotal study in Japan, focusing on the quality of life in patients with ...

Vertex Pharmaceuticals has solidified its leadership in the cystic fibrosis (CF) market through strategic innovation and ...

People with congestive heart failure, undergoing treatment for schizophrenia or who have a history of paraphilic disorders will no ...

In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...

About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...